Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > GUD will follow soon

<< Previous

Bullboard Posts

Next >>

Post by Chianchinon Apr 29, 2023 4:31pm

144 Views

Post# 35421084

GUD will follow soon

..unles MNGT and BOD walk bfore the cash runs dry. Selling generic drugs and not making a profit for many yeas is what happens to companies like Endo and inevitably GUD. In LATAM no hope foer profits the past records show it.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale